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Summary 
The activation of cytokine genes in response to anti- 
genie stimulation of T cells is mediated by NF-AT pro- 
teins. Previous studies have identified two NF-AT pro- 
teins, NF-ATp and NF-ATc, that are homologous within 
a 290 aa domain distantly related to the Rel domain. 
We have isolated two additional members of this gene 
family, M-AT3 and NF-AT4, which encode proteins 
66% identical to the other NF-AT proteins within the 
Rel domain. The four NF-AT genes are transcribed in 
different sets of tissues that included many sites of 
expression outside the immune system. The Rel ho- 
mology domain is sufficient for DNA recognition and 
cooperative blnding Interactions with AP-1. Although 
other members of the Rel family bind DNA as dimers, 
NF-AT proteins are monomers in solution or bound to 
DNA. Transfection assays indicate that each of the four 
NF-AT proteins can activate the IL-2 promoter in T 
cells. 
Introduction 
Investigation of the antigen-inducible expression of the 
interleukin-2 (IL-2) gene led to the discovery of the regula- 
tory transcription factor nuclear factor of activated T cells 
(NF-AT) (Durand et al., 1988; Shaw et al., 1988). Like sev- 
eral other transcription factors involved in mediating signal 
transduction, the activity of NF-ATappears to be regulated 
by subcellular localization (Flanagan et al., 1991; Jain et 
al., 1992). In resting T cells, NF-AT activity is restricted 
to cytoplasm; stimulation of the T cell receptor leads to 
translocation of NF-ATto the nucleus. Movement of NF-AT 
to the nucleus is dependent on the activation of the cal- 
cium-regulated phosphatase calcineurin (Clipstone and 
Crabtree, 1992). The immunosuppressive drugscyclosporin 
and FK506 inhibit the activity of calcineurin, and thereby 
prevent the nuclear localization of NF-AT and subsequent 
activation of cytokine gene expression (reviewed by 
Schreiber and Crabtree, 1992). 
Activation of the T cell antigen receptor induces two 
signaling pathways required for IL-2 induction, one is the 
cyclosporin-sensitive calcium-dependent pathway and the 
other relies on the activation of protein kinase C (PKC). 
Antigenic stimulation of these pathways can be mimicked 
by treating cells with a calcium ionophore and a phorbol 
ester. The PKC-inducible activity was found to be medi- 
ated by fos and jun proteins (Jain et al., 1992; Northrop 
et al., 1993). The NF-AT binding site in the IL-2 promoter 
is adjacent to a weak binding site for AP-1 proteins, and 
NF-AT and AP-1 proteins bind cooperatively to this cc 
posite element (Jain et al., 1993b; Northrop et al., 19! 
The transcriptional activation mediated by AP-1 prote 
through this site appears to be critical for IL-2 express 
in activated T cells. There are several different combi 
tions of fos and jun family members that can interact I 
NF-AT to bind DNA (Boise et al., 1993; Northrop et 
1993; Jain et al., 1994; Yaseen et al., 1994). Therefc 
the composition of the AP-1 complex that interacts \ 
NF-AT may vary in different cell types and different sta 
of T cell activation. 
NF-AT was originally reported to be a T cell-spec 
transcription factor critical for the restricted expressio 
IL-2 (Shaw et al., 1988). More recently, NF-AT activity’ 
detected in B cells (Brabletz et al., 1991; Yaseen et 
1993; Choi et al., 1994; Venkataraman et al., 1994). . 
is consistent with the finding that, in transgenic mice, 
major sites of expression of a reporter gene regulates 
the IL-2 NF-ATIAP-1 site are activated T and B cells ( 
weij et al., 1990). 
In addition to 11-2, NF-AT sites have been discovc 
in the promoters of several other cytokine genes, inclu 
IL-4 (Chuvpilo et al., 1993; Szabo et al., 1993; Room 
al., 1994) IL-3 (Cockerill et al., 1993) granulocyte-ma 
phage colony-stimulating factor (GM-CSF; Masuda e 
1993) and tumor necrosis, factor-a (TNFa; Goldfeld e 
1993). Thus, it appears that NF-AT proteins are invo 
in the coordinate regulation of many different cytok 
in activated lymphocytes. As with 11-2, most of the NI 
sites in other cytokine promoters are composite elem 
that also contain AP-1 binding sites (Rao, 1994). 
The purification of NF-AT proteins that bind specifi 
to the IL-2 antigen response element have been led tr 
isolation of two distinct genes (Jain et al., 1993a; Mc 
frey et al., 1993a; Northrop et al., 1994). These two ge 
designated NFATp and NF-ATc, encode related pro 
that are highlysimilartoeachotherwithina29Oaador 
This NF-AT homology region shares weak sequence 
larity with the DNA binding and dimerization doma 
the Rel family of transcription factors (reviewed by N’ 
1994). There is evidence that both NF-ATp and NF 
may be involved in mediating transcriptional regulati 
activated T cells. For example, NF-ATp forms a sp 
complex on DNA with fos and jun that activates tran: 
tion in vitro (McCaffrey et al., 1993a). NF-ATc has 
shown to activate IL-2 expression by a cotransfe 
assay in T cells (Northrop et al., 1994). Furthermore, 
proteins appear to be modified by calcineurin (Jain r 
1993a; Northrop et al., 1994). 
In the course of investigating the mechanisms inv 
in cytokine gene transcription, we have isolated ( 
clones encoding human NF-AT genes. In additjon t 
ATp and /VF-AR, we have isolated two new membc 
this gene family by virtue of their sequence homolc 
the Rel similarity region. We have used these clan 
examine the tissue distribution of the different h 
genes. We have also compared the DNA binding ant 
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scriptional activation functions of the NF-AT family pro- 
teins. 
Results 
Figure 1. cDNA Clones Analyzed in this Study 
(A) For W-AT3 three overlapping cDNA clones isolated from a Jurkat 
cell cDNA library spanning a distance of 2.9 kb were sequenced. The 
NF-AT4 sequence was derived from four overlapping clones. For NF- 
AT4 there are three different classes of 3’ ends that are related by 
alternative RNA processing. These three forms are designated NF- 
AT4a, NF-AT4b, and NF-AT4c. cDNAs of the 4a and 4c class were 
isolated from the Jurkat cell library. cDNAs from the 4b and 4c class 
Cloning of Human NF-AT Genes 
cDNA libraries were prepared from Jurkat T cells and hu- 
man peripheral blood lymphocytes (PBLs), and screened 
using a probe derived from the Rel similarity region of the 
murine NF-ATp gene (McCaffrey et al., 1993a). Cross- 
hybridizing clones were isolated, sequenced, and deter- 
mined to be derived from four distinct genes. 
One of the genes isolated in this study is the human 
homolog of the Nf-ATp gene (McCaffrey et al., 1993a), 
and another is identical to the NF-ATc gene (Northrop et 
al., 1994). We have isolated two classes of NF-ATp cDNAs, 
which are the result of alternative splicing upstream of the 
Rel domain. One form is similar to the cDNA reported by 
McCaffreyet al. (1993a), while the other is missing an exon 
encoding the region near the N terminus of the protein and 
has a different initiating methionine (data not shown). 
In addition to these previously identified genes, we 
cloned two novel members of the NF-AT gene family, 
hereby designated as NF-AT3 and NF-AT4. The NF-AT3 
sequence was obtained from three overlapping cDNAs 
spanning 2880 bp, and deduced to encode a protein of 
902 aa (Figure 1A and 1B). We obtained three classes 
of NF-AT4 cDNAs that resulted from alternative splicing 
downstream of the Rel homology domain (Figure 1A). These 
three types of cDNAs encode proteins that vary in se- 
quence and length at their C-terminal ends. The three forms 
are designated NF-AT4a, NF-AT4b, and NF-AT4c. The 
amino acid sequences of NF-AT4 are shown in Figure 1C. 
All of the NFAT genes are at least 65% identical to each 
other within a 290 aa domain (Figure 2). This domain is 
related to the DNA binding and dimerization domain of 
the Rel family of transcription factors (Nolan, 1994; Northrop 
et al., 1994). Among the different NFAT genes, the N-termi- 
nal and central portions of the Rel similarity domain are 
more highly conserved than the C terminus. 
Aside from the strikingly similar Rel domains shared by 
all four NF-AT genes, the NF-AT family members have 
smaller regions of sequence similarity on the N-terminal 
side of the Rel domains. The N-terminal regions of NF-AT4 
and NF-ATc have several regions of significant similarity. 
The two largest regions contain 23 of 41 and 24 of 45 
identical amino acids between the two proteins (Figure 
2C, designated regions A and B). Both of these regions 
are rich in serine and proline residues. NF-ATp and NF- 
AT3 also have some similarity to the other NF-AT proteins 
were cloned from a skeletal muscle cDNA library. The divergence 
begins just downstream of the Rel homology domain, indicated by the 
two different types of dashed lines. The asterisks indicate the positions 
of the stop codons. 
(B) Amino sequence of NF-AT3. 
(C) Amino acid sequence of NF-AT4. The arrowheads indicate the 
positions of splice junctions in the coding regions of the different types 
of NF-AT4 cDNAs. 
Cloning of NF-AT3 and NF-AT4 
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Figure 2. Alignment of the Rel Homology Domain of the NF-AT Pro- 
teins 
(A) The residues that are identical in all four proteins are boxed (156 
of 290, 54%). Positions that are identical or have a conservative 
change in all four proteins are shaded. The alignment was performed 
using the GeneWorks sequence analysis program (Intelligenetics). 
(B) Pair-wise comparisons of the percentage of sequence identities 
within the Rel homology domains of the four NF-AT proteins. 
(C) Alignment of NF-AT sequences in the N-terminal regions of the 
proteins. Three regions of homology, designated A, B, and C, are 
indicated by the shaded boxes. The amino acid sequences of the 
homogous regions are shown below. 
in this region, although it is less extensive than that sha 
between NF-AT4 and NF-ATc (Figure 2C). The homolc 
between NF-AT3 and NF-AT4 extends about 25 aa 
stream of the Rel similarity region (Figure 2C, box C) 
Expression Patterns of the NF-AT Genes 
On the basis of previous reports, expression of NF, 
genes was expected to be restricted to lymphocytes (St 
et al., 1988; Verweij et al., 1990; McCaffrey et al., 199 
Northrop et al., 1994). The expression of each NF-ATg( 
was tested by Northern blot analysis using RNA from 
teen different human tissues (Figure 3). For Nf-ATp, 
pression of an mRNA approximately 7.5 kb was detec 
in almost all human tissues. The expression was slig 
higher in PBLs and placenta (Figure 3A). 
NF-ATc expression was also detected at a low Ieve 
several different tissues. The NF-ATc probe hybridize1 
two bands of approximately 2.7 and 4.5 kb. The 4.5 
NF-ATc transcript was observed to be strongly expres 
in skeletal muscle (Figure 38). The 2.7 kb mRNA app 
to correspond to the previously described NF-ATc cl 
(Northrop et al., 1994). 
NF-AT3 exhibited a very complicated expression pat 
with at least three major RNA bands between 3 and ! 
(Figure 3C). The major sites of W-AT3 expression H 
observed outside the immune system. NF-AM was hi! 
expressed in placenta, lung, kidney, testis, and ovaq 
contrast, NF-AT3 expression was very weak in spleen 
thymus and undetectable in PBLs. 
NF-AT4 was expressed predominately as a 6.5 kb n 
sage. It is likely that this transcript corresponds to the 
class of cDNAs. Like NF-ATc, NF-AT4 was strongly 
pressed in skeletal muscle (Figure 3D). NF-AT4 also 
played relatively high expression in thymus. The PI 
for the NF-AT4 Northern blots contained the 3’ half 01 
NF-AT homology region as well as downstream reg 
from the NFAT4c class of cDNA. This probe shoulc 
bridize to all three classes of NF-AT4 transcripts. Only 
form is detected in the Northern blots, suggesting tha 
4c class is the most abundant transcript. 
These results indicate that each of the NF-AT genf 
expressed in a distinct tissue-specific pattern. Furl 
more, none of the NF-AT genes are restricted to lym 
cytes. 
DNA Binding Activity of the NF-AT Proteins 
The Rel similarity regions along with a small amour 
flanking sequences of each of the four classes of NI 
proteins were expressed in Escherichia coli. Each o 
four proteins was well expressed and soluble (Figur 
The proteins were purified to near homogeneity by 
affinity chromatography (Kadonaga and Tjian, 1986). 
binding site used for purification was a high affinity Nl 
site derived from the IL4 promoter with the core bir 
sequence GGMAATUT (Rooney et al., 1994). 
The binding specificities of the NFAT proteins 
tested on two known functional binding sites, the IL-4 
mater NF-AT site and the NF-AT binding site in the ( 
antigen response element from the IL-2 promoter (Du 
et al., 1988; Shawet al., 1988). All theproteinswereal 
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Figure 3. Northern Blot Analysis of NF-AT Expression 
Northern blots with 2 ug of poly(A)+ RNA from various human tissues were hybridized with probes specific for each of the NF-AT genes as indicated 
above the autoradiograms. Each of the NF-AT genes exhibits a different pattern of tissue specific expression. 
(A) NF-ATp is expressed as a 7.5 kb mRNA; the highest levels are in PBLs, placenta, and muscle. 
(6) Two NF-ATc messages of 2.7 and 4.5 kb are detected. The larger NF-ATc transcript is very abundant in skeletal muscle. 
(C) The NF-AT3 probe hybridized to three RNA species between 3 and 5 kb. The major sites of NF-AT3 expression are placenta, lung, kidney, 
testis, and ovary. 
(D) NF-AT4, like NF-ATc, shows particularly strong expression in skeletal muscle. It is also highly expressed in thymus. The positions of RNA size 
markers are indicated on the left of the gels. 
bind the IL4 promoter site. NFATp, NF-ATc, and NF-AT3 
recognized this sequence with very similar affinity, while 
NF-AT4 bound this sequence with an apparently lower 
affinity in thisassay(>lO-fold)than theotherthreeproteins 
(Figure 5A). 
The same amounts of the four NF-AT proteins were 
tested on the NF-AT binding site from the human IL-2 pro- 
moter (Figure 59). This NF-AT site (GGAAAAACTG) has 
three differences relative to the IL4 site, which make it a 
weaker site for all four NF-AT proteins. The NF-AT proteins 
differ in their ability to recognize this site independently. 
NF-ATp had the highest relative affinity for the IL-2 binding 
site, while NF-ATc and NF-AT3 bound weakly to this site 
and NFAT4 binding was not detectable in this assay. 
The IL-2 NF-AT site is part of a composite element that 
is adjacent to a weak AP-1 site (TGllTCA) (Jain et al., 
1992; Northrop et al., 1993). To determine whether there 
were any differences in the ability of NF-AT proteins to 
interact with AP-1, the four NF-AT proteins were tested 
with AP-1 for binding to the IL-2 site (Figure 5C). When 
tested alone, all the NF-AT proteins, as well as the AP-1 
proteins, bound relatively weakly to the IL-2 composite 
element. The combination of cJun and fral with each of 
the four NF-AT proteins resulted in highly cooperative 
DNA binding. In the presence of the AP-1 protein, the four 
NF-AT proteins bound to the IL-2 site with very similar 
affinity (Figure 5C, compare lanes 3, 6, 9, and 12). In all 
cases, jun homodfmers were not as effective as jun-fral 
heterodimers in promoting cooperative binding in the gel 
shift assay. These results indicate that the DNA binding 
and protein interaction specificity of the NF-AT proteins 
are very similar. Indeed, the interactions of the four NF-AT 
proteins with these AP-1 proteins appear to be identical. 
NF-AT4 did not bind independently to this site, but recog- 
tZZ5ning of NF-AT3 and NF-AT4 
into HepG2 ceils resulted in activation of the reporter gt 
of at least 20-fold in the presence of PMA and ionomyc 
In contrast with Jurkat cells, NF-AT3 was more potent tt 
the others in the HepG2 transfections, resulting in 140-i 
activation (Figure 86). Mutation of the NF-AT site in 
multimerized composite element completely elimina 
trans-activation by each of the NF-AT proteins (data 
shown). Unlike Jurkat cells, in HepGP cells the NF-AT [ 
teins appeared to activate transcription in the absence 
PMA or calcium ionophore. Treatment of the cells resul 
in further stimulation of transcription. 
29- 
In COS cells, NF-AT3 produced a striking 50-fold act 
tion that was observed independently of PMA and ic 
mycin treatment. NF-AT3 was found to stimulate transc 
tion in COS cells much more strongly than the other protc 
(Figure 8C). 
12345 6 7 8 9 NF-AT Proteins Are Active as Monomers 
Figure 4. Expression atid Purification of Recombinant NF-AT Proteins 
Portions of the NF-AT cDNAs containing the Rel homology domain 
and small amounts of flanking sequences were cloned into a T7 poly- 
merase expression vector and produced in E. coli. Control extracts 
were prepared from induced cells carrying the expression vector with 
no insert. Lanes l-5 are 10 pg of protein from the soluble fraction of 
the extracts prepared from the control and the NF-AT-expressing cells. 
The NF-AT proteins were purified by DNA affinity chromatography 
using a high affinity binding site from the IL-4 promoter. The four puri- 
fied NF-AT proteins are shown in lanes 6-9. The gel was stained with 
Coomassie blue. 
There are many similar features of the NF-AT and 
families of transcription factors. Rel proteins form ha 
and heterodimers in solution, and dimerization is requ 
for DNA binding (reviewed by Baeuerle and Henkel, 19 
The C-terminal half of the Rel homology domain is thou 
to be involved in mediating dimerization. Since the sirr 
ity between NF-AT and the Rel families extends throw 
out the 300 aa Rel domain, and the Rel domain oi 
NF-KB proteins is sufficient for dimer formation, we 
petted that the NF-AT proteins might also be functio 
as dimers. To test this idea, we determined the ni 
masses of the NF-AT proteins by gel filtration chrome 
raphy and glycerol gradient centrifugation. For these 
periments, we used the Rel similarity regions of NF- 
and NF-ATc that were expressed in E. coli and pur 
by DNA affinity chromatography. The molecular ma 
of these proteins are 40.4 and 35.8 kDa, respectively 
acontrol, we used purified NF-KB ~50 protein that is kn 
to exist as a stable dimer in solution (Baeuerle and f 
more, 1989). The p50 protein is 45.8 kDa calculated 
its amino acid sequence. 
On both the gel filtration column and the glycerol g 
ent, the NF-ATp and NF-ATc Rel domains migrated 
position close to their actual molecular masses (Fig 
7A and 78). Under the same conditions, p50 behaved 
species that was larger than its monomer molecular rr 
The data from the gel filtration column was used to c, 
late the Stokes radius of each protein, and the S vz 
were determined by glycerol gradient sedimenta 
These two properties were used to calculate the appc 
molecular size of the proteins (Siegel and Monty, 1 
Thompson et al., 1991). The apparent molecular sizl 
the NF-ATp and NF-ATc Rel domains were determint 
be 42 kDa and 32 kDa, respectively. These valuer 
close to the monomer molecular mass for both NF-Al 
teins. As expected, p50 exhibited an apparent mole 
size close to that of a dimer. 
nized this site with the same affinity as the other NF-AT 
proteins in the presence of AP-1. 
Transcriptional Activation by the NF-AT Proteins 
Having established that the DNA binding properties of the 
four NF-AT proteins are similar, we investigated their tran- 
scriptional activation potentials. We used atransient trans- 
fection assay into Jurkat T cells to measure the ability of 
the NF-AT proteins to activate the IL-2 promoter. The IL-2 
promoter was chosen because it is a critical regulatory 
target for NF-AT and has at least two functional NF-AT 
binding sites (Randak et al., 1990). Activation of this pro- 
moter by antigenic stimulation can be mimicked by treat- 
ment with phorbol esters, such as phorbol 12.myristate 
13acetate(PMA), togetherwith ionomycin, acalcium iono- 
phore. 
Each of the four NF-AT genes was transfected into Jur- 
kat cells, and their ability to activate the IL-2 promoter was 
tested with various combinations of PMA and ionomycin. 
Treatment of the cells with PMA plus ionomycin induced 
strong activation by the endogenous NF-AT proteins in 
Jurkat cells. Transfection of each of the four of the NF-AT 
genes resulted in an additional stimulation the IL-2 pro- 
moter between 4- and d-fold (Figure 8A). Activation of the 
IL-2 promoter by each of the NF-AT proteins was depen- 
dent on both PMA and ionomycin. 
We also tested the ability of NF-AT to activate transcrip- After determining that NF-AT Rel domains were n 
tion in COS and HepG2 cells using a synthetic reporter mers in solution, we then considered the possibilit) 
gene consisting of three copiesof an NF-ATIAP-1 compos- NF-AT proteins might form dimers when bound to I 
ite element. Transfection of each of the four NF-AT genes To address this question, we carried out gel mobility 
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assays with two different sized versions of NF-ATc trans- 
lated in vitro (Hope and Struhl, 1987). The shorter version 
contains the Rel similarity region and a small amount of 
flanking residues and is referred to as NF-ATc-309. This 
construct is equivalent to the one that was expressed in 
E. coli (see Figure 4). The larger version, NF-ATc-589, 
contains additional N-terminal sequences. When expressed 
individually in a rabbit reticulocyte lysate, both versions 
of NF-ATc were active and produced protein-DNA com- 
plexes with different mobilities (Figure 8). When the two 
different NF-ATc proteins were mixed by cotranslation, 
the same protein-DNA complexes were apparent and no 
intermediate species was detectable, as would be ex- 
pected if the proteins were forming dimers on the DNA. 
Figure 5. The Different NF-AT Proteins Have Similar DNA Binding 
Activities 
(A) Electrophoretic mobility shift assays using a binding site derived 
from the IL-4 promoter. The core binding site has the sequence 
GGAAAATFFT. Equal amounts of the four NF-AT proteins were used 
for each set of reactions. The proteins were titrated over a lO-fold 
range with the three reactions containing approximately 0.3 nM, 1 nM, 
and 3 nM of NF-AT protein. Reactions in lanes l-3 were carried out 
with NF-ATp protein; lanes 4-6 contain NF-ATc; lanes 7-9 contain 
NF-AT3 and lanes 10-12 contain NF-AT4. NF-AT4 bound to this se- 
quence less well than the other three NF-AT proteins. 
(B) Electrophoretic mobility shift assay using an IL-2 promoter NF-AT 
binding site. The same amounts of proteins were used as in (A). NF- 
ATp binds with the highest relative affinity, while the other proteins 
bind less well than they bind to the IL-4 site. 
(C)Cooperative DNA binding by each of the NF-AT proteins with AP-1. 
The labeled DNA was from the IL-2 promoter (-265 to -255). Binding 
reactions were carried out with NF-AT alone (lanes 1,4,7, lo), NF-AT 
plus cJun (lanes 2, 5, 6, 1 l), or NF-AT plus cJun and fra-1 (lanes 3. 
6. 9, 12). Reactions in lane 13 contain cJun, and lane 14 contains 
cJun plus fra-1. The binding of each of the four NF-AT proteins and 
AP-1 to this composite element is mutually cooperative. In the pres- 
ence of cJun and fra-I, all four NF-AT proteins bind this site with 
similar affinity. The concentration of each of the NF-AT proteins was 
- 1 nM and the concentrations of cJun and fra-1 were -5 nM. 
1 2 3 4 5 6 7 8 9 10 1112 
These results suggest that NF-AT proteins are capable of 
sequence-specific DNA binding as monomers. 
Similarity of the NF-AT and Rel Gene Families 
We have isolated two new members of the NF-AT gene 
family, NF-AT3 and NF-AT4, that are at least 95% identical 
to NF-ATp and NF-ATc within a 290 aa region. This region 
is sufficient for sequence-specific DNA binding as well as 
interaction with fos and jun proteins. The NF-AT proteins 
display limited homology to the Rel family of transcription 
factors throughout this entire domain. Although the per- 
centage of sequence identity is low, there are several fea- 
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Figure 6. Transcriptional Activation by NF-AT Proteins in Transfected Cells 
(A) Each of the NF-AT genes was expressed in Jurkat cells, and activity was assayed using the IL-2 promoter (-326 to +47) regulating lucifen 
The cells were either untreated (minus), or treated with ionomycin (I), PMA (P), or both ionomycin and PMA (I+P). Control transfections H 
carried out with the RSV expression vector with no insert. Treatment of the cells with PMA plus ionomycin activated the reporter gene thro 
the endogenous proteins in Jurkat cells. Transfection of the NF-AT expression vectors lead to a further stimulation between 4-and &fold. Lucifer 
activity was standardized to the cells transfected with the empty expression vector treated with PMA and ionomycin. 
(8) The same expression constructs were transfected into HepGP cells. The reporter gene for this experiment contained three copies of the NF. 
AP-1 composite element from the IL-2 promoter upstream of a minimal promoter. Transfection of each of the four NF-AT genes strongly active 
transcription of the reporter gene between 20- and 14gfold in the presence of PMA and ionomycin. In all cases, there is a significant activa 
in the absence of PMA + ionomycin. 
(C)The same constructs were used to transfect COS cells as in the HepGP experiments. NF-AT3 was the only protein that was a strong transcriptit 
activator in COS cells. 
tures of the NF-AT and Rel families that are consistent to be more dependent than the Rel family proteinson co 
with the idea that they are evolutionarily related. For exam- erative binding interactions with leucine zipper protei 
ple, both NF-AT proteins and Rel family proteins function Most functional NF-AT sites identified thus far appear 
in mediating signal transduction events involved in the be linked to AP-1 sites (Rao, 1994). Mutational analp 
immune response, and both sets of proteins are regulated of the NF-ATp Rel domain suggests that a region r-r 
by nuclear localization. Furthermore, both NF-AT and Rel the N terminus is involved in DNA recognition, as is 
proteins interact with B-zip proteins to cooperatively bind homologous region in the NF-KB proteins (Jain et 
to DNA (reviewed by Nolan, 1994). NF-AT proteins appear 1995). 
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Figure 7. Determination of the Native Molecular Sizes of the NF-AT Rel Domains 
(A) Gel filtration chromatography using a Superdex-POO column. The elution volumes of the molecular mass standards are plotted versus tl 
of their molecular mass. The elution positions of NF-ATc, NF-ATp, and p50 dimers are indicated. The following standards were used: thyrogli 
(669 kDa), 6-amylase (200 kDa), BSA (66 kDa), carbonic anhydrase (29 kDa), and cytochrome c (12.4 kDa). 
(B)Glycerol gradient sedimentation analysis. The same molecular mass standards were used as for the gel filtration column, except that thyrogl’ 
was omitted. The sedimentation positions of NF-ATc, NF-ATp, and ~50 dimers are indicated. 
(C) Calculation of the native molecular sizes of NF-ATp, NF-ATc and ~50 using the gel filtration and glycerol gradient data. The first colt 
the actual molecular mass calculated from the amino sequence of each protein. For NF-ATp and NF-ATc. this includes an eight amino tag 
N terminus. The Stokes radii and S values were determined relative the molecular weight standards from the data in (A) and (8). The apl 
molecular masses were determined from the Stokes radii, S values, and partial specific volumes. 
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Figure 9. NF-AT Bind DNA as Monomers 
Gel mobility shift assay with two different sized versions of the NFATc 
protein. NF-ATc-399 and NF-ATc-569 were translated seperately 
(lanes 1 and 4) or mixed together by cotranslation (lanes 2 and 3). 
The two proteins produced gel shift complexes with distinct mobilities, 
and no intermediate complexes were observed after mixing. The bind- 
ing site was a site from the IL-4 promoter (the same as in Figure 5A). 
The fact that there is only -20% (or less) sequence 
identity between the NF-AT and Rel proteins suggests that 
there may be some structural and functional differences 
between the two classes. One difference appears to be 
related to dimerization. Here we show that, in contrast 
with the Flel family members, which function as obligate 
dimers, the NF-AT proteins are capable of DNA binding 
as monomers. Consistent with these findings, the C termi- 
nus of the NF-ATp Rel domain was found to be unneces- 
sary for DNA binding (Jain et al., 1995). Structural studies 
of the ~50 Rel domain indicated that the C-terminal region 
contains the dimer interface (Ghosh et al., 1995; Muller 
et al., 1995). The Rel domains of the NF-AT class may 
have some different structural features that allow for se- 
quence-specific DNA recognition by monomers. 
Functional Differences Among NF-AT Protelns 
Our results establish that there are at least four highly 
related NF-AT proteins. These genes were identified by 
cross-hybridization at moderately high stringency from T 
cell libraries. There may be additional NF-AT family mem- 
bers that are less homologous or are not expressed in T 
cells. The fact that there are so many NF-AT genes was 
unexpected, based on the previous analyses of NF-AT 
activity in T lymphocytes. Why are there so many NF-AT 
genes? One possibility is that the different NF-AT proteins 
could have different binding and transcriptional activities 
and are regulating distinct target genes during T cell acti- 
vation. The data in Figure 5 suggest that the NF-AT4 pro- 
tein may have a different optimum binding sequence than 
the other NF-AT proteins. Alternatively, this difference in 
activity may reflect DNA-binding properties of the proteins 
that are particularly important for the gel shift binding 
assay. Comparison of the DNA binding activities of the 
four proteins in DNasel footprint assays with a variety of 
functional NF-AT binding sites indicate that the four NF-AT 
proteins have similar binding specificities (T. H., unpub- 
lished data). Furthermore, the ability to interact with AP-1 
proteins to bind cooperatively to a composite element ap- 
pears to be very similar in all four NFAT proteins. In addi- 
tion, all four NF-AT proteins appear to be able to transacti- 
vate the IL-2 promoter in a cotransfection assay. These 
results suggest that the proteins might be largely redun- 
dant in their functions. 
Which of the NF-AT proteins are mediating T cell acti- 
vation? There are few apparent biochemical differences 
between the proteins; however, the genes have different 
patterns of tissue-specific expression. Since NF-AT3 expres- 
sion is low in spleen, thymus, and PBLs, NF-AM appears 
unlikely to play a major role in T cell activation. Based 
on the available data, NF-ATp, NF-ATc, and NF-AT4 all 
appear to be good candidates for functioning in T cell acti- 
vation. The clarification of the roles of the different NF-AT 
genes requires further experiments and, ultimately, knock- 
ing out the function of these genes in mice. 
The one striking difference among the four NF-AT pro- 
teins was the relatively high level of transcriptional activa- 
tion mediated by NF-AT3 in COS cells. The DNA binding 
activity of the proteins in nuclear extracts prepared from 
transfected COS cells was found to be roughly similar 
(data not shown). Therefore, the difference in transcrip- 
tional activity does not appear to be the result of differential 
expression, stability, or nuclear localization of the proteins. 
NF-AT3, which is normally not highly expressed in lympho- 
cytes, was the weakest activator in Jurkat cells. It will be 
important to explore the molecular mechanisms involved 
in this differential activity of the NF-AT proteins. Perhaps 
the proteins require a cofactor or a modification to be tran- 
scriptionally active. 
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Regulation of NF-AT Activity 
Investigation of NF-AT binding activity during the process 
of T cell activation indicated that NF-AT function is regu- 
lated by cytoplasmic to nuclear translocation (Flanagan 
et al., 1991; Jain et al., 1992). This change in cellular 
localization requires a cyclosporin-sensitive calciumdepen- 
dent signaling pathway downstream of the antigen recep 
tor in T cells. The transfection experiments presented here 
indicate that the transcription activity of all the NF-AT pro- 
teins in Jurkat cells was dependent on calcium ionophore. 
The calcium ionophore requirement may indicate that 
each of the NF-AT proteins is regulated by nuclear local- 
ization in T cells. Alternatively, calcium signaling might be 
regulating other functions of the proteins. For example, 
DNA binding activity or transcription activation domain 
function may be modulated by calcium-dependent post- 
translational modifications. The calcium ionophore re- 
quirement may also reflect, in part, the posttranslational 
regulation of AP-1 transcriptional activity in T cells (Rincon 
and Flavell, 1994; Su et al., 1994). 
In addition to ionomycin, transcriptional stimulation of 
the IL-2 promoter by NF-AT proteins in Jurkat cells was 
dependent on the activation of protein kinase C by PMA 
treatment of the cells. The PMA requirement could be due 
to the need to induce AP-1 activity to turn on the IL-2 
promoter. Cooperative interactions with AP-1 appear to 
be critical and required for NF-AT proteins to bind to the 
antigen-response element in the IL-2 promoter. PMA treat- 
ment also induces NF-KB activity, which is an activator of 
IL-2 expression (Hoyos et al., 1989). In addition to these 
mechanisms, there may be a PKC-dependent modification 
of the NF-AT proteins required for their ability to function as 
transcriptional activators. Consistent with this possibility, 
NF-ATc has been shown to be posttranslationally modified 
in Jurkat cells in response to PMA treatment (Northrop et 
al., 1994). 
In contrast with Jurkat cells, the transcriptional regula- 
tion mediated by NF-AT proteins in HepG2 cells did not 
require calcium ionophore or PMA treatment. There are 
several possible models to explain these results. For ex- 
ample, inhibitory factors that regulate the activity of NF-AT 
proteins in lymphocytes might be missing in these nonim- 
mune cells, and therefore the NF-AT proteins would have 
some constitutive activity. 
In addition to the highly conserved Rel domains of the 
NF-AT proteins, there are shorter regions of sequence 
similarity N terminal to the Rel domains. These regions 
of homology among the different NF-AT proteins probably 
indicate functionally important parts of the molecules. It 
may be significant that these regions of sequence similar- 
ity contain many potential phosphorylation sites that could 
be involved in the regulation of NF-AT activity. Currently, 
the functions of the N-terminal region of the protein are 
not known. It is not required for DNA binding or interaction 
with AP-1. Cverexpression of the N-terminal domain in 
Jurkat cells leads to a dominant-negative phenotype (North- 
rop et al., 1994), suggesting that the N-terminal domain 
can compete with the full-length protein for binding a factor 
required for NF-AT activity. This factor could be involu 
in transcriptional activation or, perhaps, the regulation 
nuclear localization. 
The Role of NF-AT Proteins in Nonimmune Cells 
It was expected that NF-AT is a T cell-specific, or at le 
lymphocyte-specific, transcription factor. However, NOI 
ern blot analyses indicate that the expression of the NF- 
genes is quite widespread. In fact, the major sites of 1 
AT3 expression are outside the immune system. It is po! 
ble that these genes are under translational control, i 
that the proteins are not present in all tissues in which 
genes are transcribed. Surprisingly, Nf-ATc and NF-k 
are strongly transcribed in skeletal muscle, a tissue t 
was not previously recognized to have NF-AT activio 
is not unreasonable to expect that NFAT proteins n 
be functioning in muscle tissue. Skeletal muscle is an 
portant site of immune reactions, and myoblasts can fu 
tion as antigen-presenting cells (reviewed by Hohlfeld i 
Engel, 1994). Again, the development of NF-AT mu1 
mice will be valuable for analyzing the requirement 
NF-AT function in muscle. 
It is possible that NF-AT proteins are involved in mc 
lating immune function and inflammatory response by I 
ulating cytokine expression in nonimmune cells. For 
ample, one potential regulatory target for NF-Al 
nonimmune cells is the IL-15 gene. IL-15 is a T cell gro 
factor that shares several biological properties with 
(Grabstein et al., 1994). However, unlike 11-2, IL-15 is 
expressed in T cells, but is highly expressed in skel 
muscle, placenta, and kidney (Grabstein et al., 19 
Each of these tissues corresponds to a site of high exp 
sion for at least one of the NF-AT genes. 
Previous analysis of NF-ATc expre’ssion failed to de 
expression in muscle cells (Northrop et al., 1994). In ( 
trast, we observe strong expression of a 4.5 kb mRN 
skeletal muscle RNA. In our case, different Northern t 
that were hybridized with two nonoverlapping fragmi 
derived from the NF-ATc gene produced identical res 
It is possible that NF-ATc has a tissue-specific prom 
or splicing pattern, and that the RNA analyses repc 
by Northrop et al. (1994) were done with a probe that ( 
not hybridize to the 4.5 kb transcript observed in mu 
cells. 
NF-AT was discovered by studying antigen-indul 
gene expression in activated T cells. More recently, ii 
found that NF-AT binding and transcription activity c 
be induced in B cells by cross-linking surface immunol 
ulin receptors, and that the induction was cyclosporin 
sitive (Choi et al., 1994; Venkataraman et al., 1994). 1 
NF-AT regulation in B cells is very analogous to its re! 
tion in T lymphocytes. In this regard, it is interesting 
we have detected the expression in of all four NF-AT g 
in human B cell lines (T. H., unpublished data). Ir 
study, we have found that NF-AT is expressed in r 
cell types that do not have antigen recognition recer 
It will be important to determine how NF-AT activity is 
trolled in nonlymphocytes and to identifythe receptor! 
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signal transduction pathways involved in this regulation. 
We anticipate that other regulatory targets for NF-AT will 
be found in addition to the cytokine genes. For example, 
receptors, kinases, or cell adhesion molecules that func- 
tion in inflammation and the immune response could be 
potential target genes for NF-AT proteins. 
Experimental Procedures 
Isolation of Human NFAT Clones 
PBLs were isolated from 2 U of blood (obtained from Irwin Memorial 
Blood Bank, San Francisco, California) by fractionation on sodium 
metrizoate/polysaccharide (Lymphoprep, Nycomed) gradients. Jurkat 
T cells were grown in RPM1 plus 10% fetal bovine serum. Total RNA 
was isolated from Jurkat cells or PBLs according to the guanidinium- 
HCI method (Chomczynski and Sacchi, 1987). Poly(A)’ RNA was puri- 
fied using oligodT magnetic beads (Promega). Random primed and 
oligo-dT primed libraries were prepared from both Ju rkat and PBL RNA 
samples. The cDNA libraries were constructed in the vector ZAPII 
(Stratagene), according to the protocol supplied by the manufacturer. 
The cDNA was size-selected for greater than 1 kb by electrophoresis 
on a 5% polyacrylamide gel prior to ligation. Each library contained 
approximately 2 x 10’ recombinant clones. Each of the four libraries 
was screened independently under the same conditions. 
Theprobefortheinitial libratyscreenwasa372 bpfragmentderived 
by polymerase chain reaction (PCR) from the C-terminal half of the 
Rel homology domain of the mouse NF-ATp gene. This region corre- 
sponds to amino acids 370-496 in the published mNF-ATp sequence 
(McCaftreyetal., 1993a). Thefragmentwaslabeled byrandom priming 
and hybridized in 1 M NaCI, 50 mM Tris (pH 7.4) 2 mM EDTA, IO x 
Denhardt’s, 0.05% SDS, and 50 &ml salmon sperm DNA at 6OOC. 
The filters were washed first in 2x SSC. 0.1% SDS, and then in 
1 x SSC, 0.1% SDS at 6O“C. Hybridizing clones were purified and 
converted into Bluescript plasmid DNA clones. The DNA sequence 
was determined using thermal cycle sequencing and the Applied Bio- 
systems 373A sequencer. Approximately 50 clones were isolated from 
the first set of screens. Sequence analysis and cross-hybridization 
experiments indicated that these clones were derived from four distinct 
genes. For NF-AT4, adiitional cDNA clones were obtained from a 
skeletal muscle cDNA library (Stratagene). The 5’ ends of the cDNA 
clones were obtained from a Jurkat cDNA library prepared as de- 
scribed above with gene-specific primers for each of the NF-AT genes. 
Northern Blots 
The Northern blots with mRNA isolated from human tissues were pur- 
chased from Clontech. DNA probes were labeled by random priming 
and hybridized in 5x SSPE, 10x Denhardt’s, 50% formamide, 2% 
SDS, 100 pglml salmon sperm DNA at 42OC. The filters were washed 
in 2 x SSC, 0.65% SDS at room temperature, and subsequently in 
0.1 x SSC. 0.1% SDS at 80°C. For NF-ATp, the probe was 1.2 kb 
cDNA fragment containing the entire Rel similarity region of NF-ATp. 
For NF-ATc, the probe was a 291 nt PCR fragment corresponding to 
the 3’ end of Rel similarity region (amino acids 597-693; Northrop et 
al., 1994). For NF-ATc, a diffeient set of blots was hybridized with a 
g.8 kb cDNA fragment located upstream of the Rel domain. The two 
different NF-ATc probes produced identical results. For NF-AT3, the 
probe,was a 0.6 kb fragment located downstream of the Rel similarity 
region corresponding to the region encoding amino acid 720 through 
the 3’ end of the clone. For NF-AT4, the probe was a 1.3 kb cDNA 
fragment corresponding to residue 549 to 963 from the 4c class of 
cDNAs. That equal amounts of RNA was loaded in each lane was 
verified by a hybridization with a p-actin probe. 
Protein Expression end Purification 
E. coli expression vectors for each NF-AT protein were constructed 
in the T7 polymerase expression vector pl7-HMK (constructed by G. 
Peterson), which has an eight amino acid (MSRRASVH) heart muscle 
kinase (hmk) site at the N terminus. Ndel sites were introduced by 
PCR using mutagenic oligonucleotides in the coding regions upstream 
of the NF-AT Rel domains, and these restriction sites were subse- 
quently used for cloning into pT7-HMK. The sizes of the different 
proteins (without the hmk sequences) are as follows: NF-ATp, 353 aa 
(the residues homologous to 185-537 according to McCaffrey et al., 
19937); NF-ATc, 309 aa (amino acids 408-716 according to Northrop 
et al., 1994); NF-AT3, 345 aa (residues 400-744); NF-AT4, 316 aa 
(residues 393-706). 
Proteins were expressed using the T7 polymerase expression sys- 
tem in the strain BL2l(DE3) (Studier and Moffat, 1986). Expression 
was induced by addition of 0.4 mM IPTG, and the cultures were shaken 
for 4 hr at room temperature. The cells were harvested, washed in 
phosphate-buffered saline, resuspended in 0.4 M KCI-HEG (25 mM 
HEPES [pH 7.91; 0.1 mM EDTA; 10% glycerol; 0.2% NP-40; 2 mM 
DTT, 0.2 mM PMSF, 0.2 mM sodium metabisulftte) and lysed by two 
cycles of freeze-thawing, followed by sonication. The lysate was spun 
in an SS34 rotor at 10,000 x g for IO min to remove insoluble material. 
NF-AT proteins were purified from the soluble fractions of the extracts 
by DNAaffinitychromatography(Kadonaga and Tjian, 1988). The bind- 
ing site sequence for the affinity resin was from the IL4 oromoter. 
TACATTGGAAAATFtTATTACAC. The DNA was biotinylated on one 
strand and coupled to avidin-agarose beads (Sigma) at a concentra- 
tion of approximately 1 mg DNAlml. Approximately 10 mg of E. coli 
extracts containing the recombinant NF-AT proteins were loaded on 
1.5 ml DNA columns equilibrated with 0.1 M KCI-HEG. The columns 
were washed successively with 0.1,0.2, and 0.4 M HEG. The specifi- 
cally bound NF-AT proteins were eluted with 1 .O M KCI-HEG. 
Fra-1 was expressed in E. coli from the vector pETI (Novagen). 
The protein was purified from the soluble fraction to approximately 
60% homogeneity by fractionation on heparin-sepharose. cJun pro- 
tein was expressed in E. coli and purified from the insoluble portion 
of the extract as previously described (Bohmann and Tjian, 1969). The 
concentrations of the purified proteins were determined by comparing 
the intensity of womassie staining with the staining intensity of bovine 
serum albumin (BSA) standards. 
DNA Binding Experiments 
Electrophoretic mobility shift assays were performed with the indicated 
amounts of proteins in 50 mM KCI, 25 mM HEPES, 0.05 mM EDTA, 
5% glycerol, 1 mM DlT with 1 pg of poly(dldC) and 100 ng of BSA. 
The binding reactions and electrophoresis were carried out at room 
temperature. The samples were run on a 5% polyacrylamide, 0.5 x 
TBE gel at 200 V. 
Transfectfons 
The full-length coding regions for each of the NFAT genes were sub- 
cloned into the RSV expression vector pREP4 (lnvitroaen). The re- 
porter plasmid was pXll&Luc (constructed by J: Fraser). It contains 
the IL-2 promoter (-326 to +47, as in Durand et al., 1988) upstream 
of the luciferase gene. Approximately 1 x IW Jurkat cells were tran- 
siently transfected by lipofection (GIBCO BRL). The cells were treated 
20 hr after transfection with 25 rig/ml PMA and 2 uM ionomvcin. and 
the cells were harvested 8 hr after induction. Transfection efficiencies 
were standardized by wtransfection of pRSV+galactosidase @-gal) 
and subsequent determination of 6gal activity. Each transfaction wn- 
tained 2 pg of expression vector, 5 pg of luciferase reporter, and 1 
pg of 8gal plasmid and 10 td of lipofectin. COS-7 and HepGP cells 
were transfected by a modification of the calcium phosphate method 
(Chen and Okayama, 1987). The reporter gene contained three copies 
of the antigen response element (-286 to -257) upstream of the herpes 
virus tyrosine kinase minimal promoter (-50 to +28) in the luciferase 
vector pGL2 (Promega). The values presented in Figure 6 are an aver- 
age of three independent experiments. 
Gel Flltratlon Columns and Glycerol Gradients 
Protein samples were run on a 2.4 ml Superdex-200 column using 
the Pharmacia Smart system. The cotumn was equilibrated with 0.5 M 
KCI-HEG at a flow rate of 80 nllmin. The elution volumes of purified 
NF-ATc, NF-ATp, and p50 were determined relative to those of molecu- 
lar mass standards. Purified ~50 was provided by 2. Cao. The following 
molecular mass standards (10 ng) were chromatographed on separate 
runs: thyroglobulin (689 kDa), 6-amylase (200 kDa), BSA (66 kDa), 
carbonic anhydrase (29 kDa), and cytochrome c (12 kDa). The elution 
volume (V.) was converted to K, by the equation, & = (v. - V,,)/V,, 
where V. is the void volume and Vi is the included volume. The Stokes 
radii were determined from a plot of (-log K# versus the Stokes 
radii of the standards (Ackers, 1970). 
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The S values were determined by glycerol gradient centrifugation. 
Glycerol gradients (5 ml. 10%-30%) were prepared using a Beckman 
density gradient former. The samples were centrifuged in a SW5OTi 
rotor at 39,000 rpm for 40 hr. After centrifugation, 200 ul fractions 
were collected and analyzed by gel electrophoresis and coomassie 
staining. The S values were determined by their sedimentation posi- 
tions relative to the standards. Native molecular sizes were determined 
from the Stokes radii (a), S values (s), and the partial specific volumes 
(V) by the method of Siegel and Monty (1966). using the equation 
M = GnNas/l-V (Thompson et al., 1991). 
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